Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 76

1.

Keratinocyte expression of MMP3 enhances differentiation and prevents tumor establishment.

McCawley LJ, Wright J, LaFleur BJ, Crawford HC, Matrisian LM.

Am J Pathol. 2008 Nov;173(5):1528-39. doi: 10.2353/ajpath.2008.080132. Epub 2008 Oct 2.

3.

A protective role for matrix metalloproteinase-3 in squamous cell carcinoma.

McCawley LJ, Crawford HC, King LE Jr, Mudgett J, Matrisian LM.

Cancer Res. 2004 Oct 1;64(19):6965-72.

4.

MMP-10 (Stromelysin-2) and MMP-21 in human and murine squamous cell cancer.

Boyd S, Virolainen S, Pärssinen J, Skoog T, van Hogerlinden M, Latonen L, Kyllönen L, Toftgard R, Saarialho-Kere U.

Exp Dermatol. 2009 Dec;18(12):1044-52. doi: 10.1111/j.1600-0625.2009.00901.x.

PMID:
19601983
5.

Ligand activation of peroxisome proliferator-activated receptor-beta/delta and inhibition of cyclooxygenase-2 enhances inhibition of skin tumorigenesis.

Bility MT, Zhu B, Kang BH, Gonzalez FJ, Peters JM.

Toxicol Sci. 2010 Jan;113(1):27-36. doi: 10.1093/toxsci/kfp212. Epub 2009 Sep 11.

6.
7.

VILIP-1 expression in vivo results in decreased mouse skin keratinocyte proliferation and tumor development.

Fu J, Jin F, Zhang J, Fong K, Bassi DE, Lopez De Cicco R, Ramaraju D, Braunewell KH, Conti C, Benavides F, Klein-Szanto AJ.

PLoS One. 2010 Apr 15;5(4):e10196. doi: 10.1371/journal.pone.0010196.

8.

Unexpected reduction of skin tumorigenesis on expression of cyclin-dependent kinase 6 in mouse epidermis.

Wang X, Sistrunk C, Rodriguez-Puebla ML.

Am J Pathol. 2011 Jan;178(1):345-54. doi: 10.1016/j.ajpath.2010.11.032. Epub 2010 Dec 23.

9.

Distinct progression-associated expression of tumor and stromal MMPs in HaCaT skin SCCs correlates with onset of invasion.

Vosseler S, Lederle W, Airola K, Obermueller E, Fusenig NE, Mueller MM.

Int J Cancer. 2009 Nov 15;125(10):2296-306. doi: 10.1002/ijc.24589.

10.

Cell type specific interleukin-6 induced responses in tumor keratinocytes and stromal fibroblasts are essential for invasive growth.

Depner S, Lederle W, Gutschalk C, Linde N, Zajonz A, Mueller MM.

Int J Cancer. 2014 Aug 1;135(3):551-62. doi: 10.1002/ijc.27951. Epub 2014 Mar 14.

12.

MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis.

Coussens LM, Tinkle CL, Hanahan D, Werb Z.

Cell. 2000 Oct 27;103(3):481-90.

13.

Constitutive expression of erbB2 in epidermis of transgenic mice results in epidermal hyperproliferation and spontaneous skin tumor development.

Kiguchi K, Bol D, Carbajal S, Beltrán L, Moats S, Chan K, Jorcano J, DiGiovanni J.

Oncogene. 2000 Aug 31;19(37):4243-54.

15.

Expression of integrin beta 6 enhances invasive behavior in oral squamous cell carcinoma.

Ramos DM, But M, Regezi J, Schmidt BL, Atakilit A, Dang D, Ellis D, Jordan R, Li X.

Matrix Biol. 2002 Apr;21(3):297-307.

PMID:
12009335
16.

Loss of differentiation of 4NQO-induced rat malignant oral keratinocytes correlates with metastatic dissemination and is associated with a reduced cellular response to TGF-beta1 and an altered receptor profile.

Davies M, Paterson IC, Stone A, Huntley S, Patel V, Curtis R, Matthews JB, Pring M, Eveson JW, Prime SS.

J Oral Pathol Med. 1999 Oct;28(9):397-405.

PMID:
10535362
17.

Matrix metalloproteinase-19 expression in keratinocytes is repressed by transcription factors Tst-1 and Skn-1a: implications for keratinocyte differentiation.

Beck IM, Müller M, Mentlein R, Sadowski T, Mueller MS, Paus R, Sedlacek R.

J Invest Dermatol. 2007 May;127(5):1107-14. Epub 2006 Dec 28.

18.

CDK2 activation in mouse epidermis induces keratinocyte proliferation but does not affect skin tumor development.

Macias E, Miliani de Marval PL, De Siervi A, Conti CJ, Senderowicz AM, Rodriguez-Puebla ML.

Am J Pathol. 2008 Aug;173(2):526-35. doi: 10.2353/ajpath.2008.071124. Epub 2008 Jul 3.

20.

Spontaneous keratinocyte cell lines representing early and advanced stages of malignant transformation of the epidermis.

Proby CM, Purdie KJ, Sexton CJ, Purkis P, Navsaria HA, Stables JN, Leigh IM.

Exp Dermatol. 2000 Apr;9(2):104-17.

PMID:
10772384

Supplemental Content

Support Center